Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole 400mg on Pharmacokinetics of SB-773812 20mg
Latest Information Update: 06 Sep 2023
At a glance
- Drugs SB 773812 (Primary) ; Ketoconazole
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors GSK
Most Recent Events
- 04 Jan 2007 New trial record.